Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02730312 |
Title | PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic Malignancies |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Xencor, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | United States | Details | |
Emory University Hospital Midtown | Atlanta | Georgia | 30308 | United States | Details | |
Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | United States | Details | |
Blood and Marrow Transplant Group of Georgia | Atlanta | Georgia | 30342 | United States | Details | |
Northside Hospital | Atlanta | Georgia | 30342 | United States | Details | |
The University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
Wexner Medical Center at The Ohio State University | Columbus | Ohio | 43210 | United States | Details | |
The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Swedish Cancer Institute | Seattle | Washington | 98104 | United States | Details |